{"id":617,"date":"2021-10-19T17:06:02","date_gmt":"2021-10-19T17:06:02","guid":{"rendered":"https:\/\/medicalmarijuanainc.com\/?p=49330"},"modified":"2021-10-19T17:06:02","modified_gmt":"2021-10-19T17:06:02","slug":"medical-marijuana-inc-subsidiary-kannaway-appoints-internationally-acclaimed-direct-sales-leader-peter-j-e-verdegem-as-vice-president","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2021\/10\/19\/medical-marijuana-inc-subsidiary-kannaway-appoints-internationally-acclaimed-direct-sales-leader-peter-j-e-verdegem-as-vice-president\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary Kannaway\u00ae Appoints Internationally-Acclaimed Direct Sales Leader Peter J.E. Verdegem as Vice President"},"content":{"rendered":"
SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire<\/u><\/a>\u00a0—\u00a0Medical Marijuana, Inc.<\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary\u00a0Kannaway\u00ae<\/a>\u00a0has hired Peter J.E. Verdegem, Ph.D., MSc, MBA, as the Company\u2019s Vice President of North America, German Speaking Countries & Product Development.<\/p>\n \u201cIn addition to his experience successfully launching direct sales operations throughout North America, Asia, and Latin America, we are excited about Peter\u2019s shared passion for driving positive global change through health and wellness,\u201d said Kannaway\u00ae CEO Blake Schroeder. \u201cPeter will lead our domestic and international expansion efforts, specifically in North America and countries where German is the primary language and will lead the company\u2019s product development initiatives.\u201d<\/p>\n Peter Verdegem is a seasoned direct sales industry leader with more than twenty years of experience. He has held executive positions at some of the world\u2019s largest and most successful direct selling companies. Verdegem has managed teams in areas such as product development and training, sales, marketing, and international operations. Throughout his career, he has taken a keen interest and focus on nutrition and wellness products, making his new role with Kannaway\u00ae a natural yet strategic fit. Peter received his MBA from Brigham Young University and his Ph.D. in Bio-Organic Chemistry and MSc in Organic Chemistry from the University of Leiden in the Netherlands.<\/p>\n \u201cI believe in the business opportunity that direct sales provides people of all backgrounds around the world and I look forward to continuing to drive this industry forward with Kannaway,\u201d said Peter J.E. Verdegem, Kannaway\u00ae Vice President of North America, German Speaking Countries & Product Development. \u201cAccording to\u00a0Grand View Research<\/a>, the global cannabidiol (CBD) market is expected to be worth $13.4 billion by 2028. This type of growth excites me, and I believe that Kannaway has the professionalism and talent it takes to dominate this industry.\u201d<\/p>\n To learn more about Kannaway\u00ae, please visit\u00a0https:\/\/kannaway.com\/<\/a>.<\/p>\n About Kannaway\u00ae About Medical Marijuana, Inc. Medical Marijuana, Inc.\u2019s headquarters is in San Diego, California, and additional information is available at\u00a0OTCMarkets.com<\/a>\u00a0or by visiting\u00a0www.medicalmarijuanainc.com<\/a>. To see Medical Marijuana, Inc.\u2019s corporate video,\u00a0click here<\/a>.<\/p>\n FORWARD-LOOKING DISCLAIMER<\/b><\/p>\n This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/p>\n FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/b><\/p>\n These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.<\/p>\n LEGAL DISCLOSURE<\/b><\/p>\n Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.<\/p>\n CONTACT:<\/b><\/p>\n
\n<\/b>Kannaway\u00ae<\/a>\u00a0is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway\u00ae currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.<\/p>\n
\n<\/b>We are a company of firsts\u00ae<\/a>. Medical Marijuana, Inc. (MJNA<\/a>) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by\u00a0Kannaway\u00ae<\/a>\u00a0and\u00a0HempMeds\u00ae<\/a>; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including\u00a0AXIM\u00ae Biotechnologies<\/a>,\u00a0<\/a>Inc<\/a>.<\/a>\u00a0and\u00a0Neuropathix<\/a>. Medical Marijuana, Inc. was named a top CBD producer by\u00a0CNBC<\/a>. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company\u2019s flagship product\u00a0Real Scientific Hemp Oil<\/a>\u00a0has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.<\/p>\n